home.social

#rrpv β€” Public Fediverse posts

Live and recent posts from across the Fediverse tagged #rrpv, aggregated by home.social.

  1. The #US government will pay #Moderna $176 million to develop an #mRNA #vaccine targeting #H5 and #H7 varieties of #pandemic #influenzaβ€”an award given as the highly #pathogenic #birdflu #virus #H5N1 continues to spread widely among US dairy #cattle.
    The funding flows through #BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (#RRPV) Consortium. Phase 3 trial anticipated to begin in 2025. arstechnica.com/science/2024/0

  2. The #US government will pay #Moderna $176 million to develop an #mRNA #vaccine targeting #H5 and #H7 varieties of #pandemic #influenzaβ€”an award given as the highly #pathogenic #birdflu #virus #H5N1 continues to spread widely among US dairy #cattle.
    The funding flows through #BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (#RRPV) Consortium. Phase 3 trial anticipated to begin in 2025. arstechnica.com/science/2024/0

  3. The government will pay $176 million to develop an targeting and varieties of β€”an award given as the highly continues to spread widely among US dairy .
    The funding flows through , the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle () Consortium. Phase 3 trial anticipated to begin in 2025. arstechnica.com/science/2024/0

  4. The #US government will pay #Moderna $176 million to develop an #mRNA #vaccine targeting #H5 and #H7 varieties of #pandemic #influenzaβ€”an award given as the highly #pathogenic #birdflu #virus #H5N1 continues to spread widely among US dairy #cattle.
    The funding flows through #BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (#RRPV) Consortium. Phase 3 trial anticipated to begin in 2025. arstechnica.com/science/2024/0

  5. The #US government will pay #Moderna $176 million to develop an #mRNA #vaccine targeting #H5 and #H7 varieties of #pandemic #influenzaβ€”an award given as the highly #pathogenic #birdflu #virus #H5N1 continues to spread widely among US dairy #cattle.
    The funding flows through #BARDA, the Biomedical Advanced Research and Development Authority, as part of a new Rapid Response Partnership Vehicle (#RRPV) Consortium. Phase 3 trial anticipated to begin in 2025. arstechnica.com/science/2024/0